Article
Drug repositioning in epilepsy reveals novel antiseizure candidates
11 Dec 2018
Abstract excerpt
Objective: Epilepsy treatment falls short in ~30% of cases. A better understanding of epilepsy pathophysiology can guide rational drug development in this difficult to treat condition. We tested a low-cost, drug-repositioning strategy to identify candidate epilepsy drugs that are already FDA-approved and might be immediately tested in epilepsy patients who require new therapies. Methods: Biopsies of spiking and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
